TScan Therapeutics, Inc. (TCRX) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 982K | 2.57M | 2.51M | 3.08M | 2.17M | 665K | 1.05M | 536K | 566K | 7.21M | 3.89M | 3.15M | 6.8M | 3.1M | 3.36M | 4.06M | 3.02M | 2.85M | 2.41M | 2.85M |
| Revenue Growth % | -54.77% | 286.01% | 139.37% | 473.88% | 283.57% | -90.78% | -73.01% | -82.97% | -91.68% | 132.99% | 15.58% | -22.39% | 125.19% | 8.44% | 39.43% | 42.42% | 49.04% | 258.99% | - | - |
| Cost of Goods Sold | 693K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.28M | 0 | 0 | 0 | 1.48M | 0 | 14.49M | 14.69M | 12.61M | 14.21M | 10.8M |
| COGS % of Revenue | 70.57% | - | - | - | - | - | - | - | - | 17.75% | - | - | - | 47.95% | - | 357.35% | 486.26% | 441.77% | 588.97% | 379.25% |
| Gross Profit | 289K | 2.57M | 2.51M | 3.08M | 2.17M | 665K | 1.05M | 536K | 566K | 5.93M | 3.89M | 3.15M | 6.8M | 1.61M | 3.36M | -10.44M | -11.67M | -9.75M | -11.79M | -7.95M |
| Gross Margin % | 29.43% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 82.25% | 100% | 100% | 100% | 52.05% | 100% | -257.35% | -386.26% | -341.77% | -488.97% | -279.25% |
| Gross Profit Growth % | -86.69% | 286.01% | 139.37% | 473.88% | 283.57% | -88.79% | -73.01% | -82.97% | -91.68% | 268.16% | 15.58% | 130.16% | 158.3% | 116.52% | 128.51% | -31.25% | -119.67% | -88.7% | - | - |
| Operating Expenses | 29.43M | 26.43M | 39.56M | 41.73M | 38.42M | 37.38M | 33.67M | 34.65M | 31.94M | 27.29M | 28.64M | 27.76M | 29.55M | 20.26M | 19.94M | 4.81M | 4.49M | 4.45M | 4.05M | 2.73M |
| OpEx % of Revenue | 2996.74% | 1029.41% | 1575.59% | 1356.6% | 1769.74% | 5620.6% | 3209.82% | 6464.55% | 5642.93% | 378.42% | 736.69% | 881.77% | 434.31% | 654.6% | 592.95% | 118.54% | 148.76% | 155.85% | 167.83% | 95.72% |
| Selling, General & Admin | 8.22M | 5.73M | 7.7M | 8.92M | 8.46M | 7.29M | 7.41M | 7.59M | 6.9M | 4.88M | 5.89M | 6.53M | 7.77M | 4.66M | 4.91M | 4.81M | 4.49M | 4.45M | 4.05M | 2.73M |
| SG&A % of Revenue | 836.76% | 223.22% | 306.57% | 289.95% | 389.54% | 1096.99% | 706.29% | 1416.04% | 1219.43% | 67.7% | 151.63% | 207.47% | 114.17% | 150.44% | 146% | 118.54% | 148.76% | 155.85% | 167.83% | 95.72% |
| Research & Development | 21.9M | 20.04M | 31.69M | 32.63M | 29.79M | 29.35M | 26.26M | 26.88M | 24.86M | 22.41M | 22.74M | 21.23M | 21.78M | 15.6M | 15.03M | 14.49M | 14.69M | 12.61M | 14.21M | 10.8M |
| R&D % of Revenue | 2230.55% | 780.64% | 1262.01% | 1060.92% | 1372.09% | 4414.14% | 2503.53% | 5014.37% | 4391.7% | 310.72% | 585.05% | 674.3% | 320.14% | 504.17% | 446.95% | 357.35% | 486.26% | 441.77% | 588.97% | 379.25% |
| Other Operating Expenses | -693K | 656K | 176K | 176K | 176K | 728K | 0 | 183K | 180K | 0 | 0 | 0 | 0 | 0 | 0 | -1000K | -1000K | -1000K | -1000K | -1000K |
| Operating Income | -29.14M | -23.86M | -37.05M | -38.65M | -36.25M | -36.71M | -32.62M | -34.11M | -31.37M | -21.36M | -24.75M | -24.61M | -22.74M | -18.65M | -16.58M | -15.25M | -16.16M | -14.2M | -15.84M | -10.68M |
| Operating Margin % | -2967.31% | -929.41% | -1475.59% | -1256.6% | -1669.74% | -5520.6% | -3109.82% | -6364.55% | -5542.93% | -296.17% | -636.69% | -781.77% | -334.31% | -602.55% | -492.95% | -375.89% | -535.02% | -497.62% | -656.8% | -374.96% |
| Operating Income Growth % | 19.62% | 35.01% | -13.58% | -13.31% | -15.55% | -71.9% | -31.82% | -38.62% | -37.95% | -14.52% | -49.28% | -61.42% | -40.71% | -31.31% | -4.65% | -42.77% | -104.13% | -81.84% | - | - |
| EBITDA | -28.45M | -23.14M | -36.28M | -37.95M | -35.57M | -36M | -31.59M | -33M | -30.12M | -20.08M | -23.46M | -23.31M | -21.24M | -17.16M | -15.33M | -14.04M | -14.97M | -13.06M | -14.79M | -10.02M |
| EBITDA Margin % | -2896.74% | -901.25% | -1445.04% | -1233.91% | -1638.51% | -5413.68% | -3011.92% | -6156.34% | -5321.38% | -278.42% | -603.6% | -740.6% | -312.27% | -554.6% | -455.75% | -346.13% | -495.47% | -457.6% | -613.02% | -351.76% |
| EBITDA Growth % | 20.03% | 35.74% | -14.84% | -15.02% | -18.1% | -79.31% | -34.66% | -41.54% | -41.78% | -16.96% | -53.08% | -66.07% | -41.93% | -31.43% | -3.66% | -40.14% | -100.94% | -76.15% | - | - |
| D&A (Non-Cash Add-back) | 693K | 723K | 767K | 698K | 678K | 711K | 1.03M | 1.12M | 1.25M | 1.28M | 1.29M | 1.3M | 1.5M | 1.48M | 1.25M | 1.21M | 1.2M | 1.14M | 1.06M | 661K |
| EBIT | -29.14M | -22.27M | -35.01M | -36.26M | -33.45M | -35.02M | -28.93M | -30.71M | -29.18M | -18.76M | -22.02M | -23.08M | -21.61M | -17.75M | -16.04M | -15.25M | -16.16M | -14.2M | -15.84M | -10.68M |
| Net Interest Income | 689K | 881K | 1.34M | 1.7M | 2.12M | 1.99M | 2.73M | 2.45M | 1.23M | 1.74M | 1.75M | 565K | 180K | -74K | 333K | 149K | 7K | 2K | 3K | 5K |
| Interest Income | 1.16M | 1.58M | 2.04M | 2.39M | 2.8M | 2.78M | 3.69M | 3.4M | 2.19M | 2.6M | 2.73M | 1.53M | 1.14M | 901K | 534K | 149K | 7K | 2K | 3K | 5K |
| Interest Expense | -689K | 702K | 699K | 689K | 679K | 784K | 958K | 952K | 959K | 852K | 982K | 969K | 956K | 975K | 201K | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 473K | 881K | 1.34M | 1.7M | 2.12M | 903K | 2.73M | 2.45M | 1.23M | 1.74M | 1.75M | 565K | 180K | -74K | 333K | 149K | 7K | 2K | 3K | 5K |
| Pretax Income | -28.67M | -22.98M | -35.71M | -36.95M | -34.13M | -35.81M | -29.89M | -31.66M | -30.14M | -19.61M | -23M | -24.05M | -22.56M | -18.72M | -16.25M | -15.1M | -16.16M | -14.2M | -15.84M | -10.67M |
| Pretax Margin % | -2919.14% | -895.09% | -1422.14% | -1201.3% | -1571.95% | -5384.81% | -2849.09% | -5906.9% | -5325.44% | -271.99% | -591.64% | -763.82% | -331.66% | -604.94% | -483.05% | -372.21% | -534.79% | -497.55% | -656.67% | -374.79% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -28.67M | -22.98M | -35.71M | -36.95M | -34.13M | -35.81M | -29.89M | -31.66M | -30.14M | -19.61M | -23M | -24.05M | -22.56M | -18.72M | -16.25M | -15.1M | -16.16M | -14.2M | -15.84M | -10.67M |
| Net Margin % | -2919.14% | -895.09% | -1422.14% | -1201.3% | -1571.95% | -5384.81% | -2849.09% | -5906.9% | -5325.44% | -271.99% | -591.64% | -763.82% | -331.66% | -604.94% | -483.05% | -372.21% | -534.79% | -497.55% | -656.67% | -374.79% |
| Net Income Growth % | 16% | 35.83% | -19.48% | -16.71% | -13.22% | -82.58% | -29.96% | -31.67% | -33.59% | -4.75% | -41.56% | -59.27% | -39.66% | -31.85% | -2.56% | -41.44% | -104.2% | -81.89% | - | - |
| Net Income (Continuing) | -28.67M | -22.98M | -35.71M | -36.95M | -34.13M | -35.81M | -29.89M | -31.66M | -30.14M | -19.61M | -23M | -24.05M | -22.56M | -18.72M | -16.25M | -15.1M | -16.16M | -14.2M | -15.84M | -10.67M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.22 | -0.18 | -0.28 | -0.28 | -0.26 | -0.30 | -0.25 | -0.28 | -0.32 | -0.21 | -0.24 | -0.51 | -0.93 | -0.78 | -0.67 | -0.62 | -0.67 | -0.59 | -0.67 | -0.45 |
| EPS Growth % | 15.38% | 40% | -12% | 0% | 18.75% | -42.86% | -4.17% | 45.1% | 65.59% | 73.08% | 64.18% | 17.74% | -38.81% | -32.2% | 0% | -37.78% | -109.38% | -78.79% | - | - |
| EPS (Basic) | -0.22 | -0.18 | -0.28 | -0.28 | -0.26 | -0.30 | -0.25 | -0.28 | -0.32 | -0.21 | -0.24 | -0.51 | -0.93 | -0.78 | -0.67 | -0.62 | -0.67 | -0.59 | -0.67 | -0.45 |
| Diluted Shares Outstanding | 129.91M | 129.86M | 129.84M | 129.73M | 129.68M | 120.79M | 118.7M | 113.43M | 94.88M | 94.84M | 94.83M | 47.21M | 24.23M | 24.08M | 24.07M | 24.06M | 23.97M | 23.91M | 23.77M | 23.97M |
| Basic Shares Outstanding | 129.91M | 129.86M | 129.84M | 129.73M | 129.68M | 120.79M | 118.7M | 113.43M | 94.88M | 94.84M | 94.83M | 47.21M | 24.23M | 24.08M | 24.07M | 24.06M | 23.97M | 23.91M | 23.77M | 23.97M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |